Identification of master genes involved in liver key functions through transcriptomics and epigenomics of methyl donor deficiency in rat: Relevance to nonalcoholic liver disease

Molecular Nutrition and Food Research

Volumn 59, Issue 2, 2015, Pages 293-302

  Chen, Gaili ^a   Broséus, Julien ^a,b   Hergalant, Sébastien ^a   Donnart, Audrey ^c   Chevalier, Catherine ^c   Bolaños Jiménez, Francisco ^d   Guéant, Jean Louis ^a,b   Houlgatte, Rémi ^a,b  

^a INSERM   (France)

^b UNIVERSITY HOSPITAL OF NANCY   (France)

^c UNIVERSITÉ DE NANTES   (France)

^d CEMAGREF   (France)

Author keywords

Fetal programing; Methyl donor deficiency; Methylome; NAFLD; Transcriptome

Indexed keywords

RATTUS;

CYANOCOBALAMIN; FOLIC ACID; TRANSCRIPTOME;

ANIMAL; BIOLOGY; BLOOD; DIET; DNA METHYLATION; EPIGENETICS; FEMALE; GENE EXPRESSION; GENETICS; LACTATION; LIPID METABOLISM; LIVER; LIVER DISEASE; MATERNAL NUTRITION; PERINATAL CARE; PHYSIOLOGY; RAT; REPRODUCIBILITY; VETERINARY; WISTAR RAT;

ANIMALS; COMPUTATIONAL BIOLOGY; DIET; DNA METHYLATION; EPIGENOMICS; FEMALE; FOLIC ACID; GENE EXPRESSION; LACTATION; LIPID METABOLISM; LIVER; LIVER DISEASES; MATERNAL NUTRITIONAL PHYSIOLOGICAL PHENOMENA; PERINATAL CARE; RATS; RATS, WISTAR; REPRODUCIBILITY OF RESULTS; TRANSCRIPTOME; VITAMIN B 12;

EID: 84922789017     PISSN: 16134125     EISSN: 16134133     Source Type: Journal    
DOI: 10.1002/mnfr.201400483     Document Type: Article

References (69)

1. Godfrey, K. M., Barker, D. J., Fetal nutrition and adult disease. Am. J. Clin. Nutr. 2000, 71, 1344S-1352S.
2. Barker, D. J., The fetal origins of coronary heart disease. Acta Paediatr. 1997, 422, 78-82.
3. Bossenmeyer-Pourie, C., Blaise, S., Pourie, G., Tomasetto, C. et al., Methyl donor deficiency affects fetal programming of gastric ghrelin cell organization and function in the rat. Am. J. Pathol. 2010, 176, 270-277.
4. Gueant, J. L., Anello, G., Bosco, P., Gueant-Rodriguez, R. M. et al., Homocysteine and related genetic polymorphisms in Down's syndrome IQ. J. Neurol. Neurosurg. Psychiatry 2005, 76, 706-709.
5. Molloy, A. M., Kirke, P. N., Brody, L. C., Scott, J. M. et al., Effects of folate and vitamin B12 deficiencies during pregnancy on fetal, infant, and child development. Food Nutr. Bull. 2008, 29, S101-S111; discussion S112-S105.
6. Garcia, M. M., Gueant-Rodriguez, R. M., Pooya, S., Brachet, P. et al., Methyl donor deficiency induces cardiomyopathy through altered methylation/acetylation of PGC-1alpha by PRMT1 and SIRT1. J. Pathol. 2011, 225, 324-335.
7. Pooya, S., Blaise, S., Moreno Garcia, M., Giudicelli, J. et al., Methyl donor deficiency impairs fatty acid oxidation through PGC-1alpha hypomethylation and decreased ER-alpha, ERR-alpha, and HNF-4alpha in the rat liver. J. Hepatol. 2012, 57, 344-351.
8. Mattson, M. P., Shea, T. B., Folate and homocysteine metabolism in neural plasticity and neurodegenerative disorders. Trends Neurosci. 2003, 26, 137-146.
9. Bosco, P., Association of IL-1 RN 2 allele and methionine synthase 2756 AA genotype with dementia severity of sporadic Alzheimer's disease. J. Neurol. Neurosur. Psychiatry 2004, 75, 1036-1038.
10. Chmurzynska, A., Fetal programming: link between early nutrition, DNA methylation, and complex diseases. Nutr. Rev. 2010, 68, 87-98.
11. Palmke, N., Santacruz, D., Walter, J., Comprehensive analysis of DNA-methylation in mammalian tissues using MeDIP-chip. Methods 2011, 53, 175-184.
12. Volkmar, M., Dedeurwaerder, S., Cunha, D. A., Ndlovu, M. N. et al., DNA methylation profiling identifies epigenetic dysregulation in pancreatic islets from type 2 diabetic patients. EMBO J. 2012, 31, 1405-1426.
13. Liang, P., Song, F., Ghosh, S., Morien, E. et al., Genome-wide survey reveals dynamic widespread tissue-specific changes in DNA methylation during development. BMC Genomics 2011, 12, 231-246.
14. Guenard, F., Tchernof, A., Deshaies, Y., Perusse, L. et al., Differential methylation in visceral adipose tissue of obese men discordant for metabolic disturbances. Physiol. Genomics 2014, 46, 216-222.
15. Gehrke, S., Brueckner, B., Schepky, A., Klein, J. et al., Epigenetic regulation of depot-specific gene expression in adipose tissue. PloS One 2013, 8, e82516.
16. Yang, Y. H., Dudoit, S., Luu, P., Lin, D. M. et al., Normalization for cDNA microarray data: a robust composite method addressing single and multiple slide systematic variation. Nucleic Acids Res. 2002, 30, e15.
17. Baron, D., Dubois, E., Bihouee, A., Teusan, R. et al., Meta-analysis of muscle transcriptome data using the MADMuscle database reveals biologically relevant gene patterns. BMC Genomics 2011, 12, 113-126.
18. Tothill, R. W., Tinker, A. V., George, J., Brown, R. et al., Novel molecular subtypes of serous and endometrioid ovarian cancer linked to clinical outcome. Clin. Cancer Res. 2008, 14, 5198-5208.
19. de Hoon, M. J., Imoto, S., Nolan, J., Miyano, S., Open source clustering software. Bioinformatics 2004, 20, 1453-1454.
20. Saldanha, A. J., Java Treeview-extensible visualization of microarray data. Bioinformatics 2004, 20, 3246-3248.
21. Wang, J., Zhang, Y., Xu, K., Mao, X. et al., Genome-wide screen of DNA methylation changes induced by low dose X-ray radiation in mice. PloS One 2014, 9, e90804.
22. Ashburner, M., Ball, C. A., Blake, J. A., Botstein, D. et al., Gene ontology: tool for the unification of biology. The Gene Ontology Consortium. Nat. Genet. 2000, 25, 25-29.
23. Zeeberg, B. R., Feng, W., Wang, G., Wang, M. D. et al., GoMiner: a resource for biological interpretation of genomic and proteomic data. Genome Biol. 2003, 4, R28.
24. Okuda, S., Yamada, T., Hamajima, M., Itoh, M. et al., KEGG Atlas mapping for global analysis of metabolic pathways. Nucleic Acids Res. 2008, 36, W423-W426.
25. Weber, M., Hellmann, I., Stadler, M. B., Ramos, L. et al., Distribution, silencing potential and evolutionary impact of promoter DNA methylation in the human genome. Nat. Genet. 2007, 39, 457-466.
26. Chen, Y., Chen, Y., Zhao, L., Chen, Y. et al., Inflammatory stress exacerbates hepatic cholesterol accumulation via disrupting cellular cholesterol export. J. Gastroenterol. Hepatol. 2012, 27, 974-984.
27. Liao, Y. J., Chen, T. L., Lee, T. S., Wang, H. A. et al., Glycine N-methyltransferase deficiency affects Niemann-Pick type C2 protein stability and regulates hepatic cholesterol homeostasis. Mol. Med. 2012, 18, 412-422.
28. Ueta, C. B., Fernandes, G. W., Capelo, L. P., Fonseca, T. L. et al., Beta(1) Adrenergic receptor is key to cold- and diet-induced thermogenesis in mice. J. Endocrinol. 2012, 214, 359-365.
29. Yoneda, M., Hotta, K., Nozaki, Y., Endo, H. et al., Association between angiotensin II type 1 receptor polymorphisms and the occurrence of nonalcoholic fatty liver disease. Liver Int. 2009, 29, 1078-1085.
30. Zain, S. M., Mohamed, Z., Mahadeva, S., Rampal, S. et al., Susceptibility and gene interaction study of the angiotensin II type 1 receptor (AGTR1) gene polymorphisms with non-alcoholic fatty liver disease in a multi-ethnic population. PloS One 2013, 8, e58538.
31. Guzman, C., Benet, M., Pisonero-Vaquero, S., Moya, M. et al., The human liver fatty acid binding protein (FABP1) gene is activated by FOXA1 and PPARalpha; and repressed by C/EBPalpha: implications in FABP1 down-regulation in nonalcoholic fatty liver disease. Biochim. Biophys. Acta 2013, 1831, 803-818.
32. Jin, J., Iakova, P., Breaux, M., Sullivan, E. et al., Increased expression of enzymes of triglyceride synthesis is essential for the development of hepatic steatosis. Cell Rep. 2013, 3, 831-843.
33. Moya, M., Benet, M., Guzman, C., Tolosa, L. et al., Foxa1 reduces lipid accumulation in human hepatocytes and is down-regulated in nonalcoholic fatty liver. PloS One 2012, 7, e30014.
34. Adams, L. A., White, S. W., Marsh, J. A., Lye, S. J. et al., Association between liver-specific gene polymorphisms and their expression levels with nonalcoholic fatty liver disease. Hepatology 2013, 57, 590-600.
35. Chowdhry, S., Nazmy, M. H., Meakin, P. J., Dinkova-Kostova, A. T. et al., Loss of Nrf2 markedly exacerbates nonalcoholic steatohepatitis. Free Radic. Biol. Med. 2010, 48, 357-371.
36. Gupte, A. A., Lyon, C. J., Hsueh, W. A., Nuclear factor (erythroid-derived 2)-like-2 factor (Nrf2), a key regulator of the antioxidant response to protect against atherosclerosis and nonalcoholic steatohepatitis. Curr. Diab. Rep. 2013, 13, 362-371.
37. Kay, H. Y., Kim, W. D., Hwang, S. J., Choi, H. S. et al., Nrf2 inhibits LXRalpha-dependent hepatic lipogenesis by competing with FXR for acetylase binding. Antioxid. Redox Signal. 2011, 15, 2135-2146.
38. Hussein, O., Zidan, J., Abu Jabal, K., Shams, I. et al., Paraoxonase activity and expression is modulated by therapeutics in experimental rat nonalcoholic fatty liver disease. Int. J. Hepatol. 2012, 2012, Article ID 265305.
39. Yamaguchi, M., Murata, T., Involvement of regucalcin in lipid metabolism and diabetes. Metabolism 2013, 62, 1045-1051.
40. Verrijken, A., Francque, S., Mertens, I., Prawitt, J. et al., Prothrombotic factors in histologically proven nonalcoholic fatty liver disease and nonalcoholic steatohepatitis. Hepatology 2014, 59, 121-129.
41. Banasik, K., Justesen, J. M., Hornbak, M., Krarup, N. T. et al., Bioinformatics-driven identification and examination of candidate genes for non-alcoholic fatty liver disease. PloS One 2011, 6, e16542.
42. Harano, Y., Yasui, K., Toyama, T., Nakajima, T. et al., Fenofibrate, a peroxisome proliferator-activated receptor alpha agonist, reduces hepatic steatosis and lipid peroxidation in fatty liver Shionogi mice with hereditary fatty liver. Liver Int. 2006, 26, 613-620.
43. Kohjima, M., Enjoji, M., Higuchi, N., Kato, M. et al., Re-evaluation of fatty acid metabolism-related gene expression in nonalcoholic fatty liver disease. Int. J. Mol. Med. 2007, 20, 351-358.
44. Nakamuta, M., Fujino, T., Yada, R., Yada, M. et al., Impact of cholesterol metabolism and the LXRalpha-SREBP-1c pathway on nonalcoholic fatty liver disease. Int. J. Mol. Med. 2009, 23, 603-608.
45. Cordero, P., Campion, J., Milagro, F. I., Martinez, J. A., Transcriptomic and epigenetic changes in early liver steatosis associated to obesity: effect of dietary methyl donor supplementation. Mol. Genet. Metab. 2013, 110, 388-395.
46. Imai, Y., Boyle, S., Varela, G. M., Caron, E. et al., Effects of perilipin 2 antisense oligonucleotide treatment on hepatic lipid metabolism and gene expression. Physiol. Genomics 2012, 44, 1125-1131.
47. Bechmann, L. P., Gastaldelli, A., Vetter, D., Patman, G. L. et al., Glucokinase links Kruppel-like factor 6 to the regulation of hepatic insulin sensitivity in nonalcoholic fatty liver disease. Hepatology 2012, 55, 1083-1093.
48. Bechmann, L. P., Vetter, D., Ishida, J., Hannivoort, R. A. et al., Post-transcriptional activation of PPAR alpha by KLF6 in hepatic steatosis. J. Hepatol. 2013, 58, 1000-1006.
49. Sazci, A., Ozel, M. D., Ergul, E., Aygun, C., Association of nicotinamide-N-methyltransferase gene rs694539 variant with patients with nonalcoholic steatohepatitis. Genet. Test. Mol. Biomarkers 2013, 17, 849-853.
50. Leroux, A., Ferrere, G., Godie, V., Cailleux, F. et al., Toxic lipids stored by Kupffer cells correlates with their pro-inflammatory phenotype at an early stage of steatohepatitis. J. Hepatol. 2012, 57, 141-149.
51. Kitamoto, T., Kitamoto, A., Yoneda, M., Hyogo, H. et al., Targeted next-generation sequencing and fine linkage disequilibrium mapping reveals association of PNPLA3 and PARVB with the severity of nonalcoholic fatty liver disease. J. Hum. Genet. 2014, 59, 241-246.
52. Kitamoto, T., Kitamoto, A., Yoneda, M., Hyogo, H. et al., Genome-wide scan revealed that polymorphisms in the PNPLA3, SAMM50, and PARVB genes are associated with development and progression of nonalcoholic fatty liver disease in Japan. Hum. Genet. 2013, 132, 783-792.
53. Tarry-Adkins, J. L., Chen, J. H., Jones, R. H., Smith, N. H. et al., Poor maternal nutrition leads to alterations in oxidative stress, antioxidant defense capacity, and markers of fibrosis in rat islets: potential underlying mechanisms for development of the diabetic phenotype in later life. FASEB J. 2010, 24, 2762-2771.
54. Orozco-Solís, R., Matos, R. J. B., Guzman-Quevedo, O., de Souza, S. L. et al., Nutritional programming in the rat is linked to long-lasting changes in nutrient sensing and energy homeostasis in the hypothalamus. PloS One 2010, 5, e13537-e13547.
55. Burdge, G. C., Lillycrop, K. A., Phillips, E. S., Slater-Jefferies, J. L. et al., Folic acid supplementation during the juvenile-pubertal period in rats modifies the phenotype and epigenotype induced by prenatal nutrition. J. Nutr. 2009, 139, 1054-1060.
56. Blom, H. J., Smulders, Y., Overview of homocysteine and folate metabolism. With special references to cardiovascular disease and neural tube defects. J. Inherit. Metab. Dis. 2011, 34, 75-81.
57. Gueant, J. L., Gueant-Rodriguez, R. M., Anello, G., Bosco, P. et al., Genetic determinants of folate and vitamin B12 metabolism: a common pathway in neural tube defect and Down syndrome? Clin. Chem. Lab. Med. 2003, 41, 1473-1477.
58. Weingartner, J., Lotz, K., Fanghanel, J., Gedrange, T. et al., Induction and prevention of cleft lip, alveolus and palate and neural tube defects with special consideration of B vitamins and the methylation cycle. J. Orofac. Orthop. 2007, 68, 266-277.
59. Lambrot, R., Xu, C., Saint-Phar, S., Chountalos, G. et al., Low paternal dietary folate alters the mouse sperm epigenome and is associated with negative pregnancy outcomes. Nat. Commun. 2013, 4, 2889-2901.
60. Altobelli, G., Bogdarina, I. G., Stupka, E., Clark, A. J. et al., Genome-wide methylation and gene expression changes in newborn rats following maternal protein restriction and reversal by folic acid. PloS One 2013, 8, e82989.
61. Sanyal, A. J., American Gastroenterological, A., AGA technical review on nonalcoholic fatty liver disease. Gastroenterology 2002, 123, 1705-1725.
62. Anstee, Q. M., Day, C. P., The genetics of NAFLD. Nat. Rev. Gastroenterol. Hepatol. 2013, 10, 645-655.
63. Chen, B. F., Chan, W. Y., The de novo DNA methyltransferase DNMT3A in development and cancer. Epigenetics 2014, 9, 669-677.
64. Kaneda, M., Okano, M., Hata, K., Sado, T. et al., Essential role for de novo DNA methyltransferase Dnmt3a in paternal and maternal imprinting. Nature 2004, 429, 900-903.
65. Curradi, M., Izzo, A., Badaracco, G., Landsberger, N., Molecular mechanisms of gene silencing mediated by DNA methylation. Mol. Cell. Biol. 2002, 22, 3157-3173.
66. Gueant, J. L., Namour, F., Gueant-Rodriguez, R. M., Daval, J. L., Folate and fetal programming: a play in epigenomics? Trends Endocrinol. Metab. 2013, 24, 279-289.
67. Dominguez-Salas, P., Moore, S. E., Baker, M. S., Bergen, A. W. et al., Maternal nutrition at conception modulates DNA methylation of human metastable epialleles. Nat. Commun. 2014, 5, 3746.
68. Padmanabhan, N., Jia, D., Geary-Joo, C., Wu, X. et al., Mutation in folate metabolism causes epigenetic instability and transgenerational effects on development. Cell 2013, 155, 81-93.
69. Skinner, M. K., What is an epigenetic transgenerational phenotype? F3 or F2. Reprod. Toxicol. 2008, 25, 2-6.